Recent Articles

• 
  Pharmaceutical R&D

  Hanmi Exports KRW 1.9 Trillion Biologic Drug Tech to Lilly

  Hanmi Pharmaceutical headquarters building. News1 Hanmi Pharmaceutical has signed a major technology export agreement with U.S. pharmaceutical company Eli Lilly to transfer the rights to its bio-new drug candidate “sonepegletide.” On the 1st, Hanmi Pharmaceutical announced that it had signed a licen

  2026.06.02
• 
  Biosimilar

  Celltrion Seeks Canada OK for Cosentyx Biosimilar CT-P55

  Panoramic view of Celltrion headquarters. Provided by Celltrion Celltrion announced on the 1st that it has submitted a marketing authorization application for CT-P55 to Health Canada. This filing marks the first step in the global approval process for CT-P55. Cosentyx recorded global sales of approx

  2026.06.01
• 
  Pharmaceutical R&D

  Hanmi Pharma Unveils Obesity Drug Boosting Muscle Mass, Function

  Overview of key research poster abstracts to be presented by Hanmi Pharmaceutical at the American Diabetes Association Scientific Sessions (ADA 2026). Provided by Hanmi Pharmaceutical Hanmi Pharmaceutical is unveiling an innovative obesity drug that is expected to increase muscle mass while also imp

  2026.05.27
• 
  Global Investment

  Lilly, flush from obesity drugs, buys three vaccine firms

  Eli Lilly is elevating the infectious disease prevention field as a new investment destination by acquiring three vaccine companies at once. Having strengthened its cash-generation capacity with GLP-1 class drugs for obesity and diabetes, the global pharmaceutical company is now moving to secure a v

  2026.05.27
• 
  Medical / Research

  Skipping Breakfast Tied to Higher Depression Risk

  Photo = Getty Images Bank. A domestic study has found that people who frequently skip meals or have irregular meal times face a higher risk of experiencing depressive symptoms. However, eating a wide variety of foods in a balanced way appears to partially mitigate this association.The research team

  2026.05.27
• 
  MedTech

  Stroke Golden Time 4.5 Hours, Slurred Speech Demands ER

  Lee Yong-jae, Director of the Neurovascular Center in the Department of Neurosurgery at Charm Joeun Hospital, explains the significance of the golden hour in the treatment of cerebrovascular disease and the role of specialized treatment institutions. Medical correspondent and physician Lee Jin-han l

  2026.05.27
• 
  MedTech

  Hospital Cuts Stroke ‘Golden Hour’ to 77 Minutes

  Director and CEO Kim Moon-cheol performing brain surgery. The Ministry of Health and Welfare–designated cerebrovascular specialty hospital S Pohang Hospital (Director and CEO Kim Moon-cheol) is taking the lead in strengthening regional emergency medical capabilities by establishing a rapid response

  2026.05.27
• 
  AI Healthcare

  Pohang Delivers World-Class Stroke Care, Not Seoul

  Exterior view of S Pohang Hospital. There is a hospital that has addressed the chronic challenge of the domestic medical sector—concentration in the Seoul metropolitan area—through a specialized hospital system, overcome the limitations of regional healthcare, and earned recognition for its world-cl

  2026.05.27
• 
  Medical / Drug Development

  Prostate Cancer Care Enters Era of Personalized Drugs

  Professor Chung Byung-chang of the Department of Urology at Samsung Medical Center explains the latest treatment strategies for prostate cancer, the most common cancer among men, during an interview at the hospital. Medical correspondent and physician Jin-Han Lee likeday@donga.com As the Republic of

  2026.05.27
• 
  Clinical Trial

  “Lung Cancer Now a Manageable Disease With Personalized Care”

  Professor Cho Byoung-cheol of the Division of Medical Oncology at Severance Hospital said, “The biggest challenge in current lung cancer treatment is to delay resistance and to enable subsequent treatment to continue even after resistance occurs,” adding, “Recently, development of fourth-generation

  2026.05.27